Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000595392 | SCV000703818 | uncertain significance | not provided | 2017-12-26 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000802278 | SCV000942102 | likely benign | Autosomal recessive polycystic kidney disease | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000802278 | SCV001323759 | uncertain significance | Autosomal recessive polycystic kidney disease | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ambry Genetics | RCV002531030 | SCV003745721 | uncertain significance | Inborn genetic diseases | 2021-08-10 | criteria provided, single submitter | clinical testing | The c.3838C>T (p.R1280C) alteration is located in exon 32 (coding exon 31) of the PKHD1 gene. This alteration results from a C to T substitution at nucleotide position 3838, causing the arginine (R) at amino acid position 1280 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV000802278 | SCV001459386 | uncertain significance | Autosomal recessive polycystic kidney disease | 2018-06-28 | no assertion criteria provided | clinical testing |